Xiaohui Du

438 total citations
18 papers, 207 citations indexed

About

Xiaohui Du is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Xiaohui Du has authored 18 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Xiaohui Du's work include Chemokine receptors and signaling (3 papers), Estrogen and related hormone effects (3 papers) and Click Chemistry and Applications (2 papers). Xiaohui Du is often cited by papers focused on Chemokine receptors and signaling (3 papers), Estrogen and related hormone effects (3 papers) and Click Chemistry and Applications (2 papers). Xiaohui Du collaborates with scholars based in China, United States and Australia. Xiaohui Du's co-authors include Julio C. Medina, Shichang Miao, Congmin Zhang, Tassie L. Collins, Ji Ma, Karen Ebsworth, Ming Wei, Yujia Tian, Xiaoqi Chen and Bryan D. Lemon and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Xiaohui Du

18 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohui Du China 8 67 40 36 36 24 18 207
Masaaki Funata Japan 9 153 2.3× 29 0.7× 35 1.0× 37 1.0× 15 0.6× 11 363
Guorui Zhang China 10 104 1.6× 16 0.4× 23 0.6× 29 0.8× 12 0.5× 27 281
Stefan G. Kauschke Germany 10 125 1.9× 29 0.7× 17 0.5× 27 0.8× 11 0.5× 15 255
Yinliang Qi China 11 140 2.1× 19 0.5× 45 1.3× 24 0.7× 39 1.6× 36 351
Shuju Zhang China 8 134 2.0× 36 0.9× 16 0.4× 25 0.7× 36 1.5× 18 299
Zuoxian Lin China 12 161 2.4× 20 0.5× 33 0.9× 17 0.5× 6 0.3× 25 318
Lenka Weiterová Czechia 13 112 1.7× 38 0.9× 30 0.8× 56 1.6× 14 0.6× 23 365
Sophie R. Sayers United Kingdom 10 91 1.4× 21 0.5× 32 0.9× 17 0.5× 12 0.5× 10 239
Michael Yeadon United Kingdom 11 138 2.1× 17 0.4× 67 1.9× 80 2.2× 12 0.5× 17 455
Manish Malviya India 11 87 1.3× 64 1.6× 48 1.3× 50 1.4× 16 0.7× 17 301

Countries citing papers authored by Xiaohui Du

Since Specialization
Citations

This map shows the geographic impact of Xiaohui Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohui Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohui Du more than expected).

Fields of papers citing papers by Xiaohui Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohui Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohui Du. The network helps show where Xiaohui Du may publish in the future.

Co-authorship network of co-authors of Xiaohui Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohui Du. A scholar is included among the top collaborators of Xiaohui Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohui Du. Xiaohui Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Du, Xiaohui, et al.. (2025). Lomitapide: Targeting METTL3 to Overcome Osimertinib Resistance in NSCLC Through Autophagy Activation. SHILAP Revista de lepidopterología. 4(1). 1 indexed citations
2.
Zhang, Chao, Qinghua Liu, Li Zhao, et al.. (2025). Bioprinted M2 macrophage-derived extracellular vesicle mimics attenuate foreign body reaction and enhance vascularized tissue regeneration. Biofabrication. 17(3). 35007–35007. 2 indexed citations
3.
Zhao, Pengyue, et al.. (2024). Gastrointestinal metastasis of breast cancer: Exploring the path ahead. SHILAP Revista de lepidopterología. 1(4). 100055–100055. 2 indexed citations
4.
Li, Bowen, Jian Gao, Chun Chen, et al.. (2024). Exploring HONO production from particulate nitrate photolysis in representative regions of China: characteristics, influencing factors, and environmental implications. Atmospheric chemistry and physics. 24(23). 13183–13198. 1 indexed citations
5.
Yang, Jing, Xiaohui Du, Mengmeng Wang, et al.. (2024). Deciphering the Role of Shank3 in Dendritic Morphology and Synaptic Function Across Postnatal Developmental Stages in the Shank3B KO Mouse. Neuroscience Bulletin. 41(4). 583–599. 1 indexed citations
7.
Wei, Ming, Congmin Zhang, Yujia Tian, et al.. (2020). Expression and Function of WNT6: From Development to Disease. Frontiers in Cell and Developmental Biology. 8. 558155–558155. 22 indexed citations
8.
Zavorotinskaya, Tatiana, Brenda Chan, Yuping Chen, et al.. (2020). Abstract 1023: CD73 inhibition with a novel orally bioavailable small molecule blocks adenosine production and rescues T-cells activation. Cancer Research. 80(16_Supplement). 1023–1023. 2 indexed citations
9.
Du, Xiaohui, Brenda Chan, Xi Chen, et al.. (2020). Abstract 1037: Orally available small molecule CD73 inhibitor reverses immunosuppression through blocking of adenosine production. Cancer Research. 80(16_Supplement). 1037–1037. 1 indexed citations
10.
Du, Xiaohui, John Eksterowicz, Haiying Zhou, et al.. (2019). Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633). Journal of Medicinal Chemistry. 62(14). 6751–6764. 5 indexed citations
11.
Rew, Yosup, Xiaohui Du, John Eksterowicz, et al.. (2018). Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101). Journal of Medicinal Chemistry. 61(17). 7767–7784. 21 indexed citations
12.
Wang, Qi, Xiaohui Du, Fen Liu, et al.. (2017). Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKβ/NF-κB/COX-2 signaling pathway. International Journal of Oncology. 51(4). 1249–1260. 38 indexed citations
13.
Zhou, Haiying, Mallika Singh, Chris Tran, et al.. (2017). Abstract 4172: Activation of AR signaling by mifepristone enhances prostate cancer growth and impairs enzalutamide response. Cancer Research. 77(13_Supplement). 4172–4172. 4 indexed citations
14.
Chen, Xiaoqi, Jeff Mihalic, Darin J. Gustin, et al.. (2011). Discovery of potent and specific CXCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(1). 357–362. 14 indexed citations
15.
Du, Xiaohui, Mike E. Lizarzaburu, Simon Turcotte, et al.. (2011). Optimization of triazoles as novel and potent nonphlorizin SGLT2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(12). 3774–3779. 13 indexed citations
16.
Du, Xiaohui, Darin J. Gustin, Xiaoqi Chen, et al.. (2009). Imidazo-pyrazine derivatives as potent CXCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 5200–5204. 29 indexed citations
17.
Du, Xiaohui, Xiaoqi Chen, Jason Duquette, et al.. (2007). Design and optimization of imidazole derivatives as potent CXCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(2). 608–613. 26 indexed citations
18.
Du, Xiaohui, Yong-ming Yao, Rong Li, Chuanan Shen, & Huinan Yin. (2005). [Influence of sexual difference on expression of Toll-like receptor 4 and myeloid differential protein-2 mRNA in the lung in septic rats].. PubMed. 17(12). 726–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026